Perspectives on exploring hybrid LBA/LC–MS approach for clinical immunogenicity testing

Biological drug products may elicit an antidrug antibody ( ADA) response. The current widely used bridging ligand binding assay(LBA) is the gold standardfor ADAassessments in drug development, wh...